257 related articles for article (PubMed ID: 15796965)
1. Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16.
Kuroda H; Moritake H; Sawada K; Kuwahara Y; Imoto I; Inazawa J; Sugimoto T
Cancer Genet Cytogenet; 2005 Apr; 158(2):172-9. PubMed ID: 15796965
[TBL] [Abstract][Full Text] [Related]
2. Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors.
Uno K; Takita J; Yokomori K; Tanaka Y; Ohta S; Shimada H; Gilles FH; Sugita K; Abe S; Sako M; Hashizume K; Hayashi Y
Genes Chromosomes Cancer; 2002 May; 34(1):33-41. PubMed ID: 11921280
[TBL] [Abstract][Full Text] [Related]
3. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
[TBL] [Abstract][Full Text] [Related]
4. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.
Rousseau-Merck MF; Versteege I; Legrand I; Couturier J; Mairal A; Delattre O; Aurias A
Cancer Res; 1999 Jul; 59(13):3152-6. PubMed ID: 10397258
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.
Fujisawa H; Misaki K; Takabatake Y; Hasegawa M; Yamashita J
J Neurooncol; 2005 Jun; 73(2):117-24. PubMed ID: 15981100
[TBL] [Abstract][Full Text] [Related]
6. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O
J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study as a tool in differential diagnosis of pediatric malignant rhabdoid tumor.
Machado I; Noguera R; Santonja N; Donat J; Fernandez-Delgado R; Acevedo A; Baragaño M; Navarro S
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):150-8. PubMed ID: 19770707
[TBL] [Abstract][Full Text] [Related]
8. Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR.
Kohashi K; Oda Y; Yamamoto H; Tamiya S; Izumi T; Ohta S; Taguchi T; Suita S; Tsuneyoshi M
J Cancer Res Clin Oncol; 2007 Nov; 133(11):817-24. PubMed ID: 17486366
[TBL] [Abstract][Full Text] [Related]
9. Malignant rhabdoid-tumor cell line showing neural and smooth-muscle-cell phenotypes.
Sugimoto T; Hosoi H; Horii Y; Ishida H; Mine H; Takahashi K; Abe T; Ohta S; Sawada T
Int J Cancer; 1999 Aug; 82(5):678-86. PubMed ID: 10417765
[TBL] [Abstract][Full Text] [Related]
10. The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors.
Caramel J; Medjkane S; Quignon F; Delattre O
Oncogene; 2008 Mar; 27(14):2035-44. PubMed ID: 17922027
[TBL] [Abstract][Full Text] [Related]
11. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.
Versteege I; Sévenet N; Lange J; Rousseau-Merck MF; Ambros P; Handgretinger R; Aurias A; Delattre O
Nature; 1998 Jul; 394(6689):203-6. PubMed ID: 9671307
[TBL] [Abstract][Full Text] [Related]
12. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
[TBL] [Abstract][Full Text] [Related]
13. SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features.
Cho YM; Choi J; Lee OJ; Lee HI; Han DJ; Ro JY
Pathol Int; 2006 Nov; 56(11):702-6. PubMed ID: 17040295
[TBL] [Abstract][Full Text] [Related]
14. Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor.
Kusafuka T; Miao J; Yoneda A; Kuroda S; Fukuzawa M
Genes Chromosomes Cancer; 2004 Jun; 40(2):133-9. PubMed ID: 15101046
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of the rhabdoid predisposition syndrome in a child: a novel germline hSNF5/INI1 mutation and absence of c-myc amplification.
Fujisawa H; Takabatake Y; Fukusato T; Tachibana O; Tsuchiya Y; Yamashita J
J Neurooncol; 2003 Jul; 63(3):257-62. PubMed ID: 12892231
[TBL] [Abstract][Full Text] [Related]
16. INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas.
Perry A; Fuller CE; Judkins AR; Dehner LP; Biegel JA
Mod Pathol; 2005 Jul; 18(7):951-8. PubMed ID: 15761491
[TBL] [Abstract][Full Text] [Related]
17. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
[TBL] [Abstract][Full Text] [Related]
18. SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters.
Kuwahara Y; Wei D; Durand J; Weissman BE
Mol Cancer Res; 2013 Mar; 11(3):251-60. PubMed ID: 23364536
[TBL] [Abstract][Full Text] [Related]
19. The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization.
Medjkane S; Novikov E; Versteege I; Delattre O
Cancer Res; 2004 May; 64(10):3406-13. PubMed ID: 15150092
[TBL] [Abstract][Full Text] [Related]
20. [Rhadboid tumours: hSNF/INI1 deficient cancers of early childhood with aggressive behaviour].
Bourdeaut F; Dufour C; Delattre O
Bull Cancer; 2010 Jan; 97(1):37-45. PubMed ID: 20080459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
